1C
CL icon

111 Capital’s Colgate-Palmolive CL Stock Holding History

111 Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$788K Buy
9,246
+5,824
+170% +$519K 0.19% 104
2025
Q4 		$270K Sell
3,422
-2,335
-41% -$183K 0.06% 250
2025
Q3 		$460K Buy
+5,757
New +$491K 0.09% 232
2025
Q2 		– Sell
-9,373
Closed -$878K – 544
2025
Q1 		$878K Buy
9,373
+5,231
+126% +$468K 0.17% 138
2024
Q4 		$377K Buy
+4,142
New +$395K 0.08% 261

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

111 Capital's CL Position: Q1 2026 in Review

111 Capital increased its Colgate-Palmolive (CL) stake by 170% in Q1 2026, buying an estimated $519K and bringing the position to 9,246 shares worth $788K. The position accounts for 0.19% of the portfolio, ranked #104.

111 Capital first reported a position in CL in Q4 2024 and has held it in 5 quarters since. The position peaked at $878K in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • 111 Capital held 9,246 shares of Colgate-Palmolive worth $788K as of Q1 2026.
  • 111 Capital bought 5,824 Colgate-Palmolive shares in Q1 2026, an estimated $519K.
  • Colgate-Palmolive made up 0.19% of 111 Capital's portfolio in Q1 2026, its #104 holding.
  • 111 Capital first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 5 quarters since.
  • 111 Capital's Colgate-Palmolive position peaked at $878K in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.